BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38691867)

  • 1. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
    Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
    Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
    Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
    Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapeutic options and novel molecular markers in skull base chordomas.
    Gagliardi F; Boari N; Riva P; Mortini P
    Neurosurg Rev; 2012 Jan; 35(1):1-13; discussion 13-4. PubMed ID: 22006091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of clival chordomas.
    Campbell RG; Prevedello DM; Ditzel Filho L; Otto BA; Carrau RL
    Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):153-61. PubMed ID: 25692630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.
    Lebellec L; Aubert S; Zaïri F; Ryckewaert T; Chauffert B; Penel N
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):125-31. PubMed ID: 25682222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chordoma: a case series and review of the literature.
    Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
    J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy.
    Rutkowski MJ; Birk HS; Wood MD; Perry A; Nicolaides T; Ames CP; Gupta N
    J Neurosurg Pediatr; 2017 May; 19(5):531-537. PubMed ID: 28304223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
    Lebellec L; Chauffert B; Blay JY; Le Cesne A; Chevreau C; Bompas E; Bertucci F; Cupissol D; Fabbro M; Saada-Bouzid E; Duffaud F; Feuvret L; Bonneville-Levard A; Bay JO; Vauleon E; Vinceneux A; Noel G; Penel N; Mir O
    Eur J Cancer; 2017 Jul; 79():119-128. PubMed ID: 28478340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
    Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
    Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of advanced chordomas.
    Colia V; Stacchiotti S
    Eur J Cancer; 2017 Sep; 83():220-228. PubMed ID: 28750274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic seeding of skull base chordoma following endoscopic endonasal surgery.
    Fernandes Cabral DT; Zenonos GA; Fernandez-Miranda JC; Wang EW; Gardner PA
    J Neurosurg; 2018 Oct; 129(4):947-953. PubMed ID: 29271711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chordoma Genetic Aberrations and Targeted Therapies Panorama: A Systematic Literature Review.
    Agosti E; Antonietti S; Zeppieri M; Ius T; Fiorindi A; Tel A; Robiony M; Panciani PP; Fontanella MM
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731241
    [No Abstract]   [Full Text] [Related]  

  • 17. Skull base chordomas review of current treatment paradigms.
    Yaniv D; Soudry E; Strenov Y; Cohen MA; Mizrachi A
    World J Otorhinolaryngol Head Neck Surg; 2020 Jun; 6(2):125-131. PubMed ID: 32596658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors.
    Shinojima N; Ozono K; Yamamoto H; Abe S; Sasaki R; Tomita Y; Kai A; Mori R; Yamamoto T; Uekawa K; Matsui H; Nosaka K; Matsuzaki H; Komohara Y; Mikami Y; Mukasa A
    Brain Tumor Pathol; 2023 Jul; 40(3):185-190. PubMed ID: 37086325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study.
    Hong S; Mahajan A; Shinya Y; Laack NN; Link MJ; O'Brien EK; Stokken JK; Janus JR; Ho TP; Choby G; Van Gompel JJ
    J Neurosurg; 2024 Apr; 140(4):920-928. PubMed ID: 37856417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.